Status:

UNKNOWN

Use of Hair to Diagnose the Presence of Breast Cancer

Lead Sponsor:

Fermiscan Ltd

Conditions:

Breast Cancer

Eligibility:

FEMALE

20+ years

Phase:

PHASE1

PHASE2

Brief Summary

Using synchrotron X-ray diffraction, it has been reported that a hair from an individual with breast cancer exhibits a difference in its molecular structure compared to that of an individual without b...

Eligibility Criteria

Inclusion

  • Adult women (aged \>20) who are undergoing mammography, and
  • Who are willing and able to provide informed consent; and
  • Who have usable scalp and/or pubic hair

Exclusion

  • Women who have dyed or permed their scalp hair within the previous 6 weeks and whose pubic hair is unavailable;
  • Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN \[cervical intra-epithelial neoplasia\]) within 5 years.

Key Trial Info

Start Date :

December 1 2006

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT00419900

Start Date

December 1 2006

Last Update

January 9 2007

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Bankstown Diagnostic Imaging Centre

Sydney, New South Wales, Australia, 2200

2

Campbelltown Ultrascan Radiology

Sydney, New South Wales, Australia

3

Diagnostic Imaging Centre, St George Private Hospital

Sydney, New South Wales, Australia

4

Liverpool Ultrascan Radiology

Sydney, New South Wales, Australia